PremiumNVO

Novo Nordisk parts ways with HIMS: stock plunges 34%

The Danish pharmaceutical company ended its collaboration with HIMS due to concerns over 'illegal mass production and misleading marketing'.

By the SpyStocks desk · 1y ago · 2 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Telegram@TheAmericanDream5

Real-time buys, sweeps, and trading halts from the desk. Free to join.